Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose

The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 2004-06, Vol.93 (6), p.1566-1576
Hauptverfasser: Erdainç, Neşe, Göktürk, Si̇nem, Tunçay, Melda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1576
container_issue 6
container_start_page 1566
container_title Journal of pharmaceutical sciences
container_volume 93
creator Erdainç, Neşe
Göktürk, Si̇nem
Tunçay, Melda
description The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 > TX‐100 > SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004
doi_str_mv 10.1002/jps.20056
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jps_20056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916315325</els_id><sourcerecordid>JPS20056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</originalsourceid><addsrcrecordid>eNp10LtOwzAUBmALgWgpDLwAysLAkNaXOG7YoHdUFaSCOlqOYwuXkFR2Sunb45JyGWCyjvydc-wfgHME2whC3FmuXBtDSOMD0EQUwzCGiB2Cpr_DIaFR0gAnzi0hhDGk9Bg0EEU4wihqgrtJUSkrZGXKIih1MFgZu06NNEUw7uXBxlTPwXxttReiqNx1MNBayWpHZ8IDUWTBKF_L0qlTcKRF7tTZ_myBp-HgsTcOp_ejSe9mGsqIkDgkIkmZfyTGhCImsEojJbDOGEpSRQXqIpkwHWuIEZQZREoSJhBJqcgQ1VCTFriq50pbOmeV5itrXoXdcgT5Lg_u8-CfeXh7UdvVOn1V2Y_cB-DB5R4IJ0WurSikcb8cYwljXe86tduYXG3_38jvHuZfq8O6w7hKvX93CPvCY0YY5YvZiM_6t_3housL70ntlc_uzSjLnTSqkCoz1ifOs9L88cEPRHuWPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Erdainç, Neşe ; Göktürk, Si̇nem ; Tunçay, Melda</creator><creatorcontrib>Erdainç, Neşe ; Göktürk, Si̇nem ; Tunçay, Melda</creatorcontrib><description>The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 &gt; TX‐100 &gt; SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.20056</identifier><identifier>PMID: 15124214</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>binding constant ; Biological and medical sciences ; Drug Interactions ; Epirubicin - analysis ; Epirubicin - chemistry ; Epirubicin - metabolism ; Epirubicin HCl ; General pharmacology ; glucose ; Glucose - analysis ; Glucose - metabolism ; interaction ; Job's method ; Medical sciences ; NaCl ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; SDS ; Sodium Chloride - analysis ; Sodium Chloride - metabolism ; Surface-Active Agents - analysis ; Surface-Active Agents - metabolism ; surfactants ; Tween 20 ; TX100</subject><ispartof>Journal of pharmaceutical sciences, 2004-06, Vol.93 (6), p.1566-1576</ispartof><rights>2004 Wiley-Liss, Inc.</rights><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566-1576, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</citedby><cites>FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.20056$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.20056$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15779778$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15124214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erdainç, Neşe</creatorcontrib><creatorcontrib>Göktürk, Si̇nem</creatorcontrib><creatorcontrib>Tunçay, Melda</creatorcontrib><title>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 &gt; TX‐100 &gt; SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004</description><subject>binding constant</subject><subject>Biological and medical sciences</subject><subject>Drug Interactions</subject><subject>Epirubicin - analysis</subject><subject>Epirubicin - chemistry</subject><subject>Epirubicin - metabolism</subject><subject>Epirubicin HCl</subject><subject>General pharmacology</subject><subject>glucose</subject><subject>Glucose - analysis</subject><subject>Glucose - metabolism</subject><subject>interaction</subject><subject>Job's method</subject><subject>Medical sciences</subject><subject>NaCl</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>SDS</subject><subject>Sodium Chloride - analysis</subject><subject>Sodium Chloride - metabolism</subject><subject>Surface-Active Agents - analysis</subject><subject>Surface-Active Agents - metabolism</subject><subject>surfactants</subject><subject>Tween 20</subject><subject>TX100</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10LtOwzAUBmALgWgpDLwAysLAkNaXOG7YoHdUFaSCOlqOYwuXkFR2Sunb45JyGWCyjvydc-wfgHME2whC3FmuXBtDSOMD0EQUwzCGiB2Cpr_DIaFR0gAnzi0hhDGk9Bg0EEU4wihqgrtJUSkrZGXKIih1MFgZu06NNEUw7uXBxlTPwXxttReiqNx1MNBayWpHZ8IDUWTBKF_L0qlTcKRF7tTZ_myBp-HgsTcOp_ejSe9mGsqIkDgkIkmZfyTGhCImsEojJbDOGEpSRQXqIpkwHWuIEZQZREoSJhBJqcgQ1VCTFriq50pbOmeV5itrXoXdcgT5Lg_u8-CfeXh7UdvVOn1V2Y_cB-DB5R4IJ0WurSikcb8cYwljXe86tduYXG3_38jvHuZfq8O6w7hKvX93CPvCY0YY5YvZiM_6t_3housL70ntlc_uzSjLnTSqkCoz1ifOs9L88cEPRHuWPQ</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Erdainç, Neşe</creator><creator>Göktürk, Si̇nem</creator><creator>Tunçay, Melda</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200406</creationdate><title>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</title><author>Erdainç, Neşe ; Göktürk, Si̇nem ; Tunçay, Melda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4336-3a9b7520223517a2eb4ea2fd719be5a181c97f6f0210cd01ec37a13b5ad15f0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>binding constant</topic><topic>Biological and medical sciences</topic><topic>Drug Interactions</topic><topic>Epirubicin - analysis</topic><topic>Epirubicin - chemistry</topic><topic>Epirubicin - metabolism</topic><topic>Epirubicin HCl</topic><topic>General pharmacology</topic><topic>glucose</topic><topic>Glucose - analysis</topic><topic>Glucose - metabolism</topic><topic>interaction</topic><topic>Job's method</topic><topic>Medical sciences</topic><topic>NaCl</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>SDS</topic><topic>Sodium Chloride - analysis</topic><topic>Sodium Chloride - metabolism</topic><topic>Surface-Active Agents - analysis</topic><topic>Surface-Active Agents - metabolism</topic><topic>surfactants</topic><topic>Tween 20</topic><topic>TX100</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erdainç, Neşe</creatorcontrib><creatorcontrib>Göktürk, Si̇nem</creatorcontrib><creatorcontrib>Tunçay, Melda</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erdainç, Neşe</au><au>Göktürk, Si̇nem</au><au>Tunçay, Melda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2004-06</date><risdate>2004</risdate><volume>93</volume><issue>6</issue><spage>1566</spage><epage>1576</epage><pages>1566-1576</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>The interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t‐octylphenoxypolyethoxyethanol; TX‐100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (Kb) of Epirubicin to various types of micelles has been calculated by means of the Benesi‐Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 &gt; TX‐100 &gt; SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin–micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1566–1576, 2004</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>15124214</pmid><doi>10.1002/jps.20056</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2004-06, Vol.93 (6), p.1566-1576
issn 0022-3549
1520-6017
language eng
recordid cdi_crossref_primary_10_1002_jps_20056
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects binding constant
Biological and medical sciences
Drug Interactions
Epirubicin - analysis
Epirubicin - chemistry
Epirubicin - metabolism
Epirubicin HCl
General pharmacology
glucose
Glucose - analysis
Glucose - metabolism
interaction
Job's method
Medical sciences
NaCl
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
SDS
Sodium Chloride - analysis
Sodium Chloride - metabolism
Surface-Active Agents - analysis
Surface-Active Agents - metabolism
surfactants
Tween 20
TX100
title Interaction of Epirubicin HCl with Surfactants: Effect of NaCl and Glucose
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A08%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20of%20Epirubicin%20HCl%20with%20Surfactants:%20Effect%20of%20NaCl%20and%20Glucose&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Erdain%C3%A7,%20Ne%C5%9Fe&rft.date=2004-06&rft.volume=93&rft.issue=6&rft.spage=1566&rft.epage=1576&rft.pages=1566-1576&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.20056&rft_dat=%3Cwiley_cross%3EJPS20056%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15124214&rft_els_id=S0022354916315325&rfr_iscdi=true